In the United States, Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen and
a major cause of pelvic inflammatory disease.1,9,10 It is thus a logical focus for prevention efforts, but timely detection and control are hampered by the large number of asymptomatic cervical infections.1,5-11 Efforts to control chlamydial infection have been aided in recent years by the development of screening criteria for use in situations where there is a low prevalence of infection.12-17 Direct evidence that screening programs can contribute to the secondary prevention of pelvic inflammatory disease is still lacking, however. To our knowledge, no studies have experimentally verified that testing and treating women with early chlamydial infection affects their risk of subsequent pelvic inflammatory disease.
In the United States, Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen anda major cause of pelvic inflammatory disease.1,9,10 It is thus a logical focus for prevention efforts, but timely detection and control are hampered by the large number of asymptomatic cervical infections.1,5-11 Efforts to control chlamydial infection have been aided in recent years by the development of screening criteria for use in situations where there is a low prevalence of infection.12-17 Direct evidence that screening programs can contribute to the secondary prevention of pelvic inflammatory disease is still lacking, however. To our knowledge, no studies have experimentally verified that testing and treating women with early chlamydial infection affects their risk of subsequent pelvic inflammatory disease.
การแปล กรุณารอสักครู่..